1. Erythroferrone (ERFE) and Growth Differentiation Factor 15 (GDF15) Are Overexpressed in Erythroprogenitor Cells of MDS Patients and Associated with Survival. (April 2017) Authors: Mossner, M.; Stöhr, A.; Jann, J.C.; Nolte, F.; Nowak, V.; Oblaender, J.; Pressler, J.; Xanthopoulos, C.; Palme, I.; Baldus, C.; Schulze, T.; Boch, T.; Metzgeroth, G.; Neumann, M.; Hofmann, W.K.; Nowak, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Response Signature to the CD95-Ligand Inhibitor Asunercept Involve Low Serum P53 and Rankl. (April 2017) Authors: Luft, T.; Radujkovic, A.; Nowak, D.; Fricke, H.; Kunz, C.; Hofmann, W.K.; Nolte, F.; Dreger, P.; Boch, T. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and Efficacy of the Cd95-Ligand Inhibitor Asunercept in Transfusion-Dependent Patients with Low and Intermediate Risk MDS. (April 2017) Authors: Boch, T.; Luft, T.; Mossner, M.; Jann, J.C.; Nowak, D.; Schumann, C.; Klemmer, J.; Brendel, S.; Fricke, H.; Kunz, C.; Hofmann, W.K.; Nolte, F. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Transcriptomic Changes upon Ageing of Bone Marrow Derived Mesenchymal Stromal Cells and Onset of MDS. (April 2017) Authors: Jann, J.C.; Mossner, M.; Nolte, F.; Boch, T.; Nowak, V.; Palme, I.; Obländer, J.; Pressler, J.; Xanthopoulos, C.; Röhl, H.; Hofmann, W.K.; Nowak, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Topic: AS08-Treatment/AS08e-New developments - Preclinical studies: A PRE-CLINICAL PATIENT-DERIVED XENOGRAFT MODEL OF MYELODYSPLASTIC SYNDROMES DEMONSTRATES EFFICACY AND SAFETY OF ELTROMBOPAG. (September 2021) Authors: Schmitt, N.; Jann, J.-C.; Altrock, E.; Flach, J.; Danner, J.; Uhlig, S.; Streuer, A.; Knaflic, A.; Riabov, V.; Xu, Q.; Mehralivand, A.; Palme, I.; Nowak, V.; Oblaender, J.; Weimer, N.; Haselmann, V.; Jawhar, A.; Darwich, A.; Weis, C.-A.; Marx, A. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: BONE MARROW DERIVED STROMAL CELLS FROM MYELODYSPLASTIC SYNDROMES ARE ALTERED BUT NOT CLONALLY MUTATED IN VIVO. (September 2021) Authors: Jann, J.-C.; Mossner, M.; Flach, J.; Altrock, E.; Schmitt, N.; Ryabov, V.; Xu, Q.; Nowak, V.; Obländer, J.; Palme, I.; Weimer, N.; Streuer, A.; Jawhar, A.; Darwich, A.; Metzgeroth, G.; Nolte, F.; Hofmann, W.-K.; Nowak, D. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1, 3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study. (October 2016) Authors: Boch, T.; Spiess, B.; Cornely, O.A.; Vehreschild, J.J.; Rath, P.M.; Steinmann, J.; Heinz, W.J.; Hahn, J.; Krause, S.W.; Kiehl, M.G.; Egerer, G.; Liebregts, T.; Koldehoff, M.; Klein, M.; Nolte, F.; Mueller, M.C.; Merker, N.; Will, S.; Mossner, M.; Popp, H. Journal: Clinical microbiology and infection Issue: Volume 22:Number 10(2016) Page Start: 862 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 120 RESULTS OF THE MULTICENTER, PHASE II STUDY OF THE SAFETY OF LENALIDOMIDE MONOTHERAPY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) ASSOCIATED WITH AN ISOLATED DEL(5Q). Issue 1 (April 2015) Authors: Schuler, E.; Schemenau, J.; Giagounidis, A.; Haase, D.; Büsche, G.; Platzbecker, U.; Nolte, F.; Götze, K.; Schlenk, R.F.; Ganser, A.; Letsch, A.; Lübbert, M.; Schafhausen, P.; Bug, G.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 156 A NOVEL PCR-BASED ASSAY FOR TARGETED QUANTIFICATION OF DEL(5Q) IN MYELODYSPLASTIC SYNDROMES. Issue 1 (April 2015) Authors: Jann, J.C.; Nowak, D.; Nolte, F.; Fey, S.; Nowak, V.; Obländer, J.; Pressler, J.; Fabarius, A.; Haferlach, C.; Medyouf, H.; Hofmann, W.K.; Mossner, M. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 227 CD71+ ERYTHROPROGENITOR CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES DISPLAY DISTURBED REGULATION OF ERYTHROPOIESIS STIMULATING ERYTHROFERRONE (ERFE) IN ASSOCIATION WITH DIFFERENTIAL PROGNOSTIC SIGNIFICANCE. Issue 1 (April 2015) Authors: Mossner, M.; Stöhr, A.; Nolte, F.; Jann, J.C.; Fey, S.; Nowak, V.; Obländer, J.; Pressler, J.; Baldus, C.D.; Schulze, T.J.; Neumann, M.; Nowak, D.; Hofmann, W.K. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗